1015 Capital Partners’s Universal Health Services UHS Stock Holding History

1015 Capital Partners’s Portfolio UHS Stock Details UHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$716	–	629
2026 Q1	$716	Sell	4 -1	-20%	-$205	﹤0.01%	487
2025 Q4	$1.09K	Buy	+5	New	+$1.1K	﹤0.01%	417

Other funds holding UHS

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

1015 Capital Partners's UHS Position: Q2 2026 in Review

1015 Capital Partners sold out of Universal Health Services (UHS) in Q2 2026, closing a stake of 4 shares — an estimated $716 sold.

1015 Capital Partners first reported a position in UHS in Q4 2025 and held it in 2 quarters. The position peaked at $1.09K in Q4 2025. 588 funds tracked by Wall St. Rank hold UHS as of Q2 2026.

1015 Capital Partners reported no remaining Universal Health Services position as of Q2 2026 after selling out during the quarter.
1015 Capital Partners sold 4 Universal Health Services shares in Q2 2026, an estimated $716.
1015 Capital Partners first reported a position in Universal Health Services in Q4 2025 and held it in 2 quarters.
1015 Capital Partners's Universal Health Services position peaked at $1.09K in Q4 2025.
588 funds tracked by Wall St. Rank held Universal Health Services as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.